Differential effects of nicotinic acid in subjects with different LDL subclass patterns.

[1]  P. Wilson,et al.  Low density lipoprotein particle size and coronary artery disease. , 1992, Arteriosclerosis and thrombosis : a journal of vascular biology.

[2]  R. Krauss,et al.  Linkage of atherogenic lipoprotein phenotype to the low density lipoprotein receptor locus on the short arm of chromosome 19. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[3]  M J Malloy,et al.  Regression of coronary atherosclerosis during treatment of familial hypercholesterolemia with combined drug regimens. , 1990, JAMA.

[4]  H. Barakat,et al.  Influence of Obesity, Impaired Glucose Tolerance, and NIDDM on LDL Structure and Composition: Possible Link Between Hyperinsulinemia and Atherosclerosis , 1990, Diabetes.

[5]  J J Albers,et al.  Regression of coronary artery disease as a result of intensive lipid-lowering therapy in men with high levels of apolipoprotein B. , 1990, The New England journal of medicine.

[6]  M. King,et al.  Atherogenic lipoprotein phenotype. A proposed genetic marker for coronary heart disease risk. , 1990, Circulation.

[7]  R. Krauss,et al.  Inheritance of low density lipoprotein subclass patterns in familial combined hyperlipidemia. , 1990, Arteriosclerosis.

[8]  R. Krauss,et al.  Changes in lipoprotein subfractions during diet-induced and exercise-induced weight loss in moderately overweight men. , 1990, Circulation.

[9]  R. Krauss,et al.  Effect of alpha- and selective beta-blockade for hypertension control on plasma lipoproteins, apoproteins, lipoprotein subclasses, and postprandial lipemia. , 1989, The American journal of medicine.

[10]  M. King,et al.  Inheritance of low-density lipoprotein subclass patterns: results of complex segregation analysis. , 1988, American journal of human genetics.

[11]  W C Willett,et al.  Low-density lipoprotein subclass patterns and risk of myocardial infarction. , 1988, JAMA.

[12]  R. Krauss,et al.  INTERMEDIATE-DENSITY LIPOPROTEINS AND PROGRESSION OF CORONARY ARTERY DISEASE IN HYPERCHOLESTEROLAEMIC MEN , 1987, The Lancet.

[13]  D H Blankenhorn,et al.  Beneficial effects of combined colestipol-niacin therapy on coronary atherosclerosis and coronary venous bypass grafts. , 1987, JAMA.

[14]  R. Krauss,et al.  GENETIC CONTROL OF LOW-DENSITY-LIPOPROTEIN SUBCLASSES , 1986, The Lancet.

[15]  R. Krauss,et al.  Presence of Multiple Subpopulations of Lipoproteins of Intermediate Density in Normal Subjects , 1986, Arteriosclerosis.

[16]  J. Albers,et al.  Contrasting effects of unmodified and time-release forms of niacin on lipoproteins in hyperlipidemic subjects: clues to mechanism of action of niacin. , 1985, Metabolism: clinical and experimental.

[17]  A. Albers,et al.  Comparison of improved precipitation methods for quantification of high-density lipoprotein cholesterol. , 1985, Clinical chemistry.

[18]  P. Kwiterovich.  HyperapoB: a pleiotropic phenotype characterized by dense low-density lipoproteins and associated with coronary artery disease. , 1988, Clinical chemistry.

[19]  R. Krauss,et al.  Nondenaturing polyacrylamide gradient gel electrophoresis. , 1986, Methods in enzymology.

[20]  R. Krauss,et al.  Identification of multiple subclasses of plasma low density lipoproteins in normal humans. , 1982, Journal of lipid research.